Researchers developed a way to directly reprogram human glial cells into PV interneurons without passing through a stem‑cell stage.
Researchers at Lund University in Sweden have created a method that makes it possible to transform the brain’s support cells ...
Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Cell Metabolism of groundbreaking preclinical data demonstrating ...
Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced preliminary in ...
Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...
Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...
Recent findings reveal Cornell prime dots can activate the immune system against melanoma, improving cancer immunotherapy ...
Regulatory alignment supports rapid progress, tech transfer already underway to accelerate clinical readiness Company on ...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Genprex ( (GNPX) ). On January 6, 2026, Genprex reported positive preliminary ...
Gadget Review on MSN
Stanford Scientists Revolutionize Arthritis Treatment with Knee Cartilage Regeneration
Stanford scientists discover how blocking 15-PGDH protein regenerates knee cartilage in mice and human tissue, offering hope ...
A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback